Europe — EMA
Octreotida Sun (Octreotide)
Octreotide, the active ingredient in Octreotida Sun, is a peptide synthetic analogue of somatostatin presented as a 100 µg/mL solution for subcutaneous injection use.
Request sourcing
What is Octreotide?
Octreotide, the active ingredient in Octreotida Sun, is a peptide synthetic analogue of somatostatin presented as a 100 µg/mL solution for subcutaneous injection use. It regulates hormone secretion and is employed in the management of hormone‑secreting tumours and related complications.
GNH USA supplies Octreotida Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.
What is Octreotide used for?
Octreotide is used across several endocrine‑related pathways, particularly targeting excess hormone production. - Acromegaly: Reduces insulin‑like growth factor‑1 and growth‑hormone levels, helping control the disease. - Carcinoid syndrome: Diminishes the frequency and severity of flushing and diarrhoea by reducing serotonin release. - VIP‑excess conditions such as VIPoma and WD‑S t … - ... … t .... t ... t ... ... ...
- .... ...
What are the side effects of Octreotide?
Common Side Effects: - ...
